In an interview, Novo Nordisk India’s managing director Vikrant Shrotriya discusses the launch of Ozempic, the company’s ...

Novo Nordisk launched Ozempic in India, pricing the lowest 0.25 mg dose at about $24 a week as it moved to tap into the ...

Doctors highlight that the drug should be administered along with a healthy diet and regular exercise for management of type 2 diabetes, and not just as cosmetic procedure for weight loss.

Danish pharma major Novo Nordisk on Friday launched its blockbuster type 2 diabetes treatment injection Ozempic, globally ...

Novo Nordisk launched its blockbuster diabetes drug Ozempic, pricing the 0.25 mg dose at $24.35 per week, aiming to capture a ...

Novo Nordisk has officially launched Ozempic in India for diabetes care. Here's how the injectable works, its dosage options, ...

Japan's Metabo Law, enacted in 2008, nudges adults aged 40-74 towards healthier lifestyles through mandatory waist ...

Novo Nordisk says it is taking a flexible portfolio approach and plans to price the injectable semaglutide close to Wegovy’s ...

The managing director of Novo Nordisk India on Ozempic’s delayed launch in India, leading the fight against diabetes and ...

The launch comes amid the company’s legal battle with Indian drugmakers, including Dr Reddy’s Laboratories and Sun Pharma, ...

With India facing over 101 million cases of diabetes and rising obesity levels, the drug could play a significant role in ...

India’s drug regulator, the Central Drugs Standard Control Organisation (CDSCO), approved Ozempic (semaglutide) for use in October this year for adults with type 2 diabetes. The company will sell the ...